Management of chronic daily headache in children

References

• Abu-Arefeh I, Russell G. Prevalence of headache and migraine in schoolchildren. BMJ309, 765–769 (1994).
   PubMed Web of Science ®Google Scholar
• Aromaa M, Sillanpaa ML, Rautava P. Childhood headache at school entry: a controlled clinical study. Neurology50, 1729–1736 (1998).
   PubMed Web of Science ®Google Scholar
• International classification of headache disorders (ICHD-II). Cephalalgia24(Suppl. 1), 23–136 (2004).
   PubMed Web of Science ®Google Scholar
• Wang SJ, Fuh JL, Lu SR, Juang KD. Chronic daily headache in adolescents: prevalence, impact, and medication overuse. Neurology66, 193–197 (2006).
   PubMed Web of Science ®Google Scholar
• Kavuk I, Yavuz A, Cetindere U, Agelink MW, Diener HC. Epidemiology of chronic daily headache. Eur. J. Med. Res.8, 236–240 (2003).
   PubMed Web of Science ®Google Scholar
• Gladstein J, Holden EW. Chronic daily headache in children and adolescents: a 2-year prospective study. Headache36, 349–351 (1996).
   PubMed Web of Science ®Google Scholar
• Mack KJ. What incites new daily persistent headache in children? Pediatr. Neurol.31, 122–125 (2004).
   PubMed Web of Science ®Google Scholar
• Gladstein J, Holden EW, Peralta L, Raven M. Diagnoses and symptom patterns in children presenting to a pediatric headache clinic. Headache33, 497–500 (1993).
   PubMed Web of Science ®Google Scholar
• Couch JR. The tension headache component of chronic daily headache. Curr. Pain Headache Rep.8, 479–483 (2004).
   PubMedGoogle Scholar
• Howard L, Wessely S, Leese M et al. Are investigations anxiolytic or anxiogenic? A randomised controlled trial of neuroimaging to provide reassurance in chronic daily headache. J. Neurol. Neurosurg. Psychiatry76, 1558–1564 (2005).
   PubMed Web of Science ®Google Scholar
• Practice parameter: the utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology44, 1353–1354 (1994).
   PubMed Web of Science ®Google Scholar
• Schwedt TJ, Guo Y, Rothner AD. ‘Benign’ imaging abnormalities in children and adolescents with headache. Headache46, 387–398 (2006).
   PubMed Web of Science ®Google Scholar
• Arnold M, Cumurciuc R, Stapf C, Favrole P, Berthet K, Bousser MG. Pain as the only symptom of cervical artery dissection. J. Neurol. Neurosurg. Psychiatry77, 1021–1024 (2006).
   PubMed Web of Science ®Google Scholar
• Evans RW. Diagnostic testing for chronic daily headache. Curr. Pain Headache Rep.11, 47–52 (2007).
   PubMedGoogle Scholar
• Maizels M, Burchette R. Somatic symptoms in headache patients: the influence of headache diagnosis, frequency, and comorbidity. Headache44, 983–993 (2004).
   PubMed Web of Science ®Google Scholar
• Rains JC. Chronic headache and potentially modifiable risk factors: screening and behavioral management of sleep disorders. Headache48(1), 32–39 (2008).
   PubMed Web of Science ®Google Scholar
• Johnson JN, Mack KJ, Kuntz NL, Brands CK, Porter CJ, Fischer PR. Postural orthostatic tachycardia syndrome – a clinical review. Pediatr. Neurol.42(2), 77–85 (2010).
   PubMed Web of Science ®Google Scholar
• Wang SJ, Juang KD, Fuh JL, Lu SR. Psychiatric comorbidity and suicide risk in adolescents with chronic daily headache. Neurology68(18), 1468–1473 (2007).
   PubMed Web of Science ®Google Scholar
• Mack KJ, Terrell KW. Chronic daily headache of childhood is a complex of multiple symptoms. American Headache Society. Headache43, 572 (2003).
   Google Scholar
• Lewis D, Ashwal S, Hershey A et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology63, 2215–2224 (2004).
   PubMed Web of Science ®Google Scholar
• Diener HC, Schorn CF, Bingel U, Dodick DW. The importance of placebo in headache research. Cephalalgia28(10), 1003–1011 (2008).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology71(8), 559–566 (2008).
   PubMed Web of Science ®Google Scholar
• Descombes S, Brefel-Courbon C, Thalamas C et al. Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot study. Headache41(2), 178–182 (2001).
   PubMed Web of Science ®Google Scholar
• Hershey AD, Powers SW, Bentti AL, Degrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache40, 539–549 (2000).
   PubMed Web of Science ®Google Scholar
• Gherpelli JL, Esposito SB. A prospective randomized double blind placebo controlled crossover study of fluoxetine efficacy in the prophylaxis of chronic daily headache in children and adolescents. Arq. Neuropsiquiatr.63(3A), 559–563 (2005).
   PubMed Web of Science ®Google Scholar
• Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ; TOPMAT-MIG-201(TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia27(7), 814–823 (2007).
   PubMed Web of Science ®Google Scholar
• Silberstein S, Lipton R, Dodick D et al. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures. Headache49(8), 1153–1162 (2009).
   PubMed Web of Science ®Google Scholar
• Lewis D, Winner P, Saper J et al. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics123(3), 924–934 (2009).
   PubMed Web of Science ®Google Scholar
• Freitag FG, Diamond S, Diamond ML, Urban GJ. Divalproex in the long-term treatment of chronic daily headache. Headache41(3), 271–278 (2001).
   PubMed Web of Science ®Google Scholar
• Yurekli VA, Akhan G, Kutluhan S, Uzar E, Koyuncuoglu HR, Gultekin F. The effect of sodium valproate on chronic daily headache and its subgroups. J. Headache Pain9(1), 37–41 (2008).
   PubMed Web of Science ®Google Scholar
• Apostol G, Lewis DW, Laforet GA et al. Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study. Headache49(1), 45–53 (2009).
   PubMed Web of Science ®Google Scholar
• Ashrafi MR, Shabanian R, Zamani GR, Mahfelati F. Sodium valproate versus propranolol in paediatric migraine prophylaxis. Eur. J. Paediatr. Neurol.9(5), 333–338 (2005).
   PubMed Web of Science ®Google Scholar
• Spira PJ, Beran RG; Australian Gabapentin Chronic Daily Headache Group. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology61(12), 1753–1759 (2003).
   PubMed Web of Science ®Google Scholar
• Pascual J, Rivas MT, Leira R. Testing the combination β-blocker plus topiramate in refractory migraine. Acta Neurol. Scand.115(2), 81–83 (2007).
   PubMed Web of Science ®Google Scholar
• Reveiz-Herault L, Cardona AF, Ospina EG, Carrillo P. Effectiveness of flunarizine in the prophylaxis of migraine: a meta-analytical review of the literature. Rev. Neurol.36(10), 907–912 (2003).
   PubMed Web of Science ®Google Scholar
• Naumann M, So Y, Argoff CE et al. Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology70, 1707–1714 (2008).
   PubMed Web of Science ®Google Scholar
• Mathew NT, Jaffri SF. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study. Headache49(10), 1466–1478 (2009).
   PubMed Web of Science ®Google Scholar
• Blumenfeld AM, Schim JD, Chippendale TJ. Botulinum toxin type A and divalproex sodium for prophylactic treatment of episodic or chronic migraine. Headache48(2), 210–220 (2008).
   PubMed Web of Science ®Google Scholar
• Aurora SK, Dodick DW, Turkel CC et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT-1 trial. Cephalalgia30, 793–803 (2010).
   PubMed Web of Science ®Google Scholar
• Diener HC, Dodick DW, Aurora SK et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia30, 804–814 (2010).
   PubMed Web of Science ®Google Scholar
• Chan VW, McCabe EJ, MacGregor DL. Botox treatment for migraine and chronic daily headache in adolescents. J. Neurosci. Nurs.41(5), 235–243 (2009).
   PubMed Web of Science ®Google Scholar
• Ahmed K, Oas KH, Mack KJ, Garza I. Experience with botulinum toxin type A in medically intractable pediatric chronic daily headache. Pediatr. Neurol. (2010) (In press).
   PubMedGoogle Scholar
• Marmura MJ, Silberstein SD, Gupta M. Hemicrania continua: who responds to indomethacin? Cephalalgia29(3), 300–307 (2009).
   PubMed Web of Science ®Google Scholar
• Bigal ME, Lipton RB. Excessive acute migraine medication use and migraine progression. Neurology71, 1821–1828 (2008).
   PubMed Web of Science ®Google Scholar
• Bailey B, McManus BC. Treatment of children with migraine in the emergency department: a qualitative systematic review. Pediatr. Emerg. Care24(5), 321–330 (2008).
   PubMed Web of Science ®Google Scholar
• Raskin NH. Repetitive intravenous ergotamine therapy for the treatment of intractable migraine. Neurology36, 995–997 (1986).
   PubMed Web of Science ®Google Scholar
• Pringsheim T, Howse D. In-patient treatment of chronic daily headache using dihydroergotamine: a long-term follow-up study. Can. J. Neurol. Sci.25(2), 146–150 (1998).
   PubMed Web of Science ®Google Scholar
• Schwartz TH, Karpitskiy VV, Sohn RS. Intravenous valproate sodium in the treatment of daily headache. Headache42, 519–522 (2002).
   PubMed Web of Science ®Google Scholar
• Prakash S, Shah ND. Post-infectious new daily persistent headache may respond to intravenous methylprednisolone. J. Headache Pain11(1), 59–66 (2010).
   PubMed Web of Science ®Google Scholar
• Trautmann E, Lackschewitz H, Kröner-Herwig B. Psychological treatment of recurrent headache in children and adolescents – a meta-analysis. Cephalalgia26(12), 1411–1426 (2006).
   PubMed Web of Science ®Google Scholar
• Coeytaux RR, Kaufman JS, Kaptchuk TJ et al. A randomized, controlled trial of acupuncture for chronic daily headache. Headache45(9), 1113–1123 (2005).
   PubMed Web of Science ®Google Scholar
• Mauskop A. Alternative therapies in headache. Is there a role? Med. Clin. North Am.85, 1077–1084 (2001).
   PubMed Web of Science ®Google Scholar
• Silberstein SD. Comprehensive management of headache and depression. Cephalalgia18(Suppl. 21), 50–55 (1998).
   PubMed Web of Science ®Google Scholar
• Wang SJ, Fuh JL, Lu SR. Chronic daily headache in adolescents: an 8-year follow-up study. Neurology73(6), 416–422 (2009).
   PubMed Web of Science ®Google Scholar